ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

INN Innovision Res.

34.75
0.00 (0.00%)
08 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Innovision Res. LSE:INN London Ordinary Share GB0030308448 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 34.75 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Directorate Change

20/11/2008 7:01am

UK Regulatory


    RNS Number : 5370I
  Innovision Research&Technology PLC
  20 November 2008
   
    Innovision Research & Technology plc 
    ("Innovision R&T")
    Board Appointment

    The Board of Innovision R&T is pleased to announce the appointment to the Board of Dr Stephen Morris as CTO with effect from 19 November
2008.  Steve joined Innovision R&T in September 2008 and has a wide range of experience of systems and complex mixed-signal IC design gained
from senior positions within UK and US based organisations.  He is a visiting Professor at the University of Westminster, has authored
nearly 30 scientific papers and contributed to several books on IC design and data converters.  He is a Fellow of the IET.

    Malcolm Baggott, Non-executive Chairman, said
    "We welcome Steve to the Board. His proven knowledge and wide experience within IC design will undoubtedly help guide and deliver the
technical strategy and IP roadmap for the company over the coming years."

 Dr Stephen John Morris, aged 59, has and/or has held the following directorships and/or partnerships in the last 5 years:

 Current directorships:                   Past directorships:
 Manor Farm Winterbourne Bassett Limited  None

    As at the date of this announcement, Dr Stephen Morris holds 10,000 ordinary shares of 1p each in Innovision R&T.

    Dr Stephen Morris confirms that there are no additional disclosures required to be made pursuant to paragraph (g) of Schedule 2 to the
AIM Rules.

    Enquiries:

    Innovision Research & Technology Plc                           Tel: 01285 888 200
    David Wollen, Chief Executive
    Brian McKenzie, Finance Director

    KBC Peel Hunt Ltd (Nominated Adviser and Broker)    Tel: 020 7418 8900
    Oliver Scott / David Anderson


This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
BOAKGMMMRLMGRZM

1 Year Innovision Research&technology Chart

1 Year Innovision Research&technology Chart

1 Month Innovision Research&technology Chart

1 Month Innovision Research&technology Chart

Your Recent History